According to UNAIDS, in 2024, about 40.8 million people around the world were living with the human immunodeficiency virus (HIV) — a virus that can lead to acquired immunodeficiency syndrome (AIDS) if ...

Add Yahoo as a preferred source to see more of our stories on Google. This photo provided by Gilead Sciences shows a vial of the company's HIV prevention medication, Yeztugo, (lenacapvir) at a ...

WASHINGTON (AP) — The U.S. has approved the world's only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It's the first step in an anticipated global rollout that could ...

PrEP is one of the most powerful tools in HIV prevention. Yet for many Black LGBTQ+ people, getting access to the medication is far harder than it should be.

With Northeast recording highest HIV prevalence, Lalrinpuii advocates ABC approach as first line of defence against HIV.

FILE - A pharmacist holds a vial of lenacapavir, an injectable HIV prevention drug, at the Desmond Tutu Health Foundation's Masiphumelele Research Site, in Cape Town, South Africa, Tuesday, July 23, ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It’s the first step in an anticipated global rollout that could protect ...

Add Yahoo as a preferred source to see more of our stories on Google. This photo provided by Gilead Sciences shows a vial of the company's HIV prevention medication, Yeztugo, (lenacapvir) at a ...

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear how many ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. WASHINGTON (AP) — The U.S. has approved the ...